MBL: mostly benign lymphocytes, but…

Slides:

Advertisements

Similar presentations

Supportive Care in Multiple Myeloma

Advertisements

Lymphoma dissemination: the other face of lymphocyte homing by Steven T. Pals, David J. J. de Gorter, and Marcel Spaargaren Blood Volume 110(9):

Benign Leukocytoses Kristine Krafts, M.D..

Use of Safety Monitoring Flow Sheets. Background  Flow sheets can serve as useful tools  Not required but recommended  Tailor for ease of use AND usefulness.

Stem cell concepts renew cancer research by John E. Dick Blood Volume 112(13): December 15, 2008 ©2008 by American Society of Hematology.

Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.

Investigating a New Methodology for the Detection of Low Frequency 17p Deleted Clones in Chronic Lymphocytic Leukaemia (CLL): Impact on Prognostic Outcome.

Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification by Paolo Strati, and.

Pathogenesis beyond the cancer clone(s) in multiple myeloma by Giada Bianchi, and Nikhil C. Munshi Blood Volume 125(20): May 14, 2015 ©2015 by.

Volume 101, Issue 4, Pages (April 1992)

Uncontrolled Wnt signaling causes leukemia

Do HSCs divide asymmetrically?

A phase 1 trial of the Fc-engineered CD19 antibody XmAb5574 (MOR00208) demonstrates safety and preliminary efficacy in relapsed CLL by Jennifer A. Woyach,

Hydroxyurea makes inflammation “just right”?

Collaboration is required for successful immunotherapy

“Vitamin hypothesis”: explanation for allergy increase?

by Christopher Dittus, and Dana Semmel

by Henrik Frederiksen, and Kai Schmidt

The antileukemic activity of Δ12-PGJ3

Finding a diamond in the (mouse is) rough

It's all in the timing by Linda J. Bendall Blood

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

by Zhenping Zhu Blood Volume 108(6): September 15, 2006

Glis: novel modulators of TCR signaling?

Successful Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant in an Acute Leukemia Patient With Chemotherapy-Induced Marrow Aplasia and Progressive.

Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response by Andreas Rosenwald, Eric Y. Chuang,

Rituximab-induced tumor cell agglutination

Tax fingerprint in adult T-cell leukemia

A cell by any other name by Narla Mohandas Blood

A young patient with multiple myeloma

Clinical response to F16-IL2 and LDAC in patients with AML bone marrow involvement. Clinical response to F16-IL2 and LDAC in patients with AML bone marrow.

Mechanisms of HIV-associated lymphocyte apoptosis

K. T. D. Thai, J. A. Wismeijer, C. Zumpolle, M. D. de Jong, M. J

A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice by Fernando E. Sepulveda, Sophia Maschalidi,

An Unusual Cause of Abdominal Pain in Sickle Cell Disease

Tophaceous gout with congenital dyserythropoietic anemia

Genetic sequence analysis of inherited bleeding diseases

Fluorescent neutrophils throw the spotlight on inflammation

In situ identification of allospecific B cells using pentamers

Polycythemia vera following autologous transplantation for AML: insights on the kinetics of JAK2V617F clonal dominance by Elisabetta Antonioli, Paola Guglielmelli,

Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency by Ronald.

Deep mining of the RBC proteome

How we choose factor VIII to treat hemophilia

Taking a leaf from the book of oral tolerance

Epstein-Barr virus–associated lymphocytosis masquerading as lymphoma

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

Stage C or not stage C…? by Claire Dearden Blood

Hyperviscosity syndrome

CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not by Naoko Ishibe, Maher Albitar, Iman.

Natural course of HTLV-1 carriers with monoclonal proliferation of T lymphocytes (“pre-ATL”) in a 20-year follow-up study by Yoshitaka Imaizumi, Masako.

The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male.

Thrombopoietin responsiveness reflects the number of doublings undergone by megakaryocyte progenitors by Jean-Michel Paulus, Najet Debili, Frédéric Larbret,

Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report by Richard L.

Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.

Caught in transformation

Immunotherapy for acute lymphoblastic leukemia: from famine to feast

Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases Elizabeth O. Stenger, Kuang-Yueh Chiang, Ann.

Volume 69, Issue 2, Pages (January 2006)

B Cells and Transplantation: An Educational Resource

d a c b CD8 CD3 CD4 CD62L HLA-DR CD57 10% 85% 11% 76% 19% 60% 36% 66%

Figure 1 Evolution of blood cell counts during 18-month treatment and follow-up (A) Mean white blood cell count, (B) mean lymphocyte count, (C) mean eosinophil.

by Geling Li, Emily Waite, and Julie Wolfson

Kinetics of clone appearance, size, persistence, and lineage content.

Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin by Sarah L. Reeves, Hannah K. Jary, Jennifer.

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

Building pattern  Complete the following tables and write the rule 

Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma

Relation between the total white blood count and the absolute lymphocyte count prior to the first vaccination and the response to vaccination. Relation.

Stem cell transplant in MF: it’s time to personalize

Illustration of the point-counting technique applied to estimate hippocampal volume from MR images of a control (C, top row), patient with left-sided seizure.

Presentation transcript:

MBL: mostly benign lymphocytes, but… by Gerald E. Marti Blood Volume 118(25):6480-6481 December 15, 2011 ©2011 by American Society of Hematology

Role of absolute B-cell count in MBL and immunophenotype patterns. Role of absolute B-cell count in MBL and immunophenotype patterns. The top panel shows the absolute number of B cells as a cumulative function of the number of cases dividing low-count MBL (normal white blood cell count, absolute lymphocyte count) from clinical MBL (with lymphocytosis). The bottom panel from left to right shows the 3 major immunophenotypic patterns seen in MBL. Gerald E. Marti Blood 2011;118:6480-6481 ©2011 by American Society of Hematology